Deregulation of Scribble Promotes Mammary Tumorigenesis and Reveals a Role for Cell Polarity in Carcinoma

Cell

Volumn 135, Issue 5, 2008, Pages 865-878

  Zhan, Lixing ^a   Rosenberg, Avi ^a,b   Bergami, Kenneth C ^a   Yu, Min ^a   Xuan, Zhenyu ^a   Jaffe, Aron B ^c   Allred, Craig ^d   Muthuswamy, Senthil K ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CELLBIO; HUMDISEASE

Indexed keywords

CELL PROTEIN; SCRIBBLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; BREAST TUMOR; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CARCINOMA; CELL COMMUNICATION; CELL DEATH; CELL INTERACTION; CELL POLARITY; CELL PROLIFERATION; CELL TRANSFORMATION; DEREGULATION; DOWN REGULATION; DYSPLASIA; GENE LOCATION; MORPHOGENESIS; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION;

MAMMALIA; MUS;

EID: 56349098933     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2008.09.045     Document Type: Article

References (65)

1. Aguilar-Cordova E., Strange R., Young L.J., Billy H.T., Gumerlock P.H., and Cardiff R.D. Viral Ha-ras mediated mammary tumor progression. Oncogene 6 (1991) 1601-1607
2. Allred C.A., Hilsenback S.G., and Mohsin S.K. Biological features of human premalignant breast disease. In: Harris J., Lippman M.E., Morrow M., and Osborne K. (Eds). Diseases of the Breast (2004), Lippincott Williams & Wilkins, Philadelphia 507-520
3. Allred D.C., Mohsin S.K., and Fuqua S.A. Histological and biological evolution of human premalignant breast disease. Endocr. Relat. Cancer 8 (2001) 47-61
4. Amundadottir L.T., Johnson M.D., Merlino G., Smith G.H., and Dickson R.B. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth Differ. 6 (1995) 737-748
5. Amundadottir L.T., Nass S.J., Berchem G.J., Johnson M.D., and Dickson R.B. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis. Oncogene 13 (1996) 757-765
6. Aranda V., Haire T., Nolan M.E., Calarco J.P., Rosenberg A.Z., Fawcett J.P., Pawson T., and Muthuswamy S.K. Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nat. Cell Biol. 8 (2006) 1235-1245
7. Audebert S., Navarro C., Nourry C., Chasserot-Golaz S., Lecine P., Bellaiche Y., Dupont J.L., Premont R.T., Sempere C., Strub J.M., et al. Mammalian Scribble forms a tight complex with the betaPIX exchange factor. Curr. Biol. 14 (2004) 987-995
8. Audebert S., Navarro C., Nourry C., Chasserotgolaz S., Lecine P., Bellaiche Y., Dupont J., Premont R., Sempere C., and Strub J. Mammalian Scribble Forms a Tight Complex with the βPIX Exchange Factor. Curr. Biol. 14 (2004) 987-995
9. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98 (2001) 13681-13686
10. Bilder D. Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressors. Genes Dev. 18 (2004) 1909-1925
11. Bissell M.J., Radisky D.C., Rizki A., Weaver V.M., and Petersen O.W. The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 70 (2002) 537-546
12. Biswas S.C., Shi Y., Sproul A., and Greene L.A. Pro-apoptotic Bim induction in response to NGF deprivation requires simultaneous activation of three different death signaling pathways. J. Biol. Chem. 282 (2007) 29368-29374
13. Blackwell T.K., Huang J., Ma A., Kretzner L., Alt F.W., Eisenman R.N., and Weintraub H. Binding of myc proteins to canonical and noncanonical DNA sequences. Mol. Cell. Biol. 13 (1993) 5216-5224
14. Blackwell T.K., Kretzner L., Blackwood E.M., Eisenman R.N., and Weintraub H. Sequence-specific DNA binding by the c-Myc protein. Science 250 (1990) 1149-1151
15. Bryant P.J. Junction genetics. Dev. Genet. 20 (1997) 75-90
16. D'Cruz C.M., Gunther E.J., Boxer R.B., Hartman J.L., Sintasath L., Moody S.E., Cox J.D., Ha S.I., Belka G.K., Golant A., et al. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat. Med. 7 (2001) 235-239
17. Danielson K.G., Oborn C.J., Durban E.M., Butel J.S., and Medina D. Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc. Natl. Acad. Sci. USA 81 (1984) 3756-3760
18. Debnath J., Mills K.R., Collins N.L., Reginato M.J., Muthuswamy S.K., and Brugge J.S. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111 (2002) 29-40
19. Debnath J., Muthuswamy S.K., and Brugge J.S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30 (2003) 256-268
20. Deming S.L., Nass S.J., Dickson R.B., and Trock B.J. C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. Br. J. Cancer 83 (2000) 1688-1695
21. Deugnier M.A., Faraldo M.M., Teuliere J., Thiery J.P., Medina D., and Glukhova M.A. Isolation of mouse mammary epithelial progenitor cells with basal characteristics from the Comma-Dbeta cell line. Dev. Biol. 293 (2006) 414-425
22. Dow L.E., Kauffman J.S., Caddy J., Peterson A.S., Jane S.M., Russell S.M., and Humbert P.O. The tumour-suppressor Scribble dictates cell polarity during directed epithelial migration: regulation of Rho GTPase recruitment to the leading edge. Oncogene 26 (2007) 2272-2282
23. Edwards P.A. Tissue reconstitution, or transgenic mammary gland, technique for modeling breast cancer development. Cancer Treat. Res. 83 (1996) 23-36
24. Ehmann U.K., Guzman R.C., Osborn R.C., Young J.T., Cardiff R.D., and Nandi S. Cultured mouse mammary epithelial cells: normal phenotype after implantation. J. Natl. Cancer Inst. 78 (1987) 751-757
25. Eilers M., Picard D., Yamamoto K.R., and Bishop J.M. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340 (1989) 66-68
26. Evan G.I., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z., and Hancock D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69 (1992) 119-128
27. Frank S.R., and Hansen S.H. The PIX-GIT complex: a G protein signaling cassette in control of cell shape. Semin. Cell Dev. Biol. 19 (2008) 234-244
28. Gardiol D., Kuhne C., Glaunsinger B., Lee S.S., Javier R., and Banks L. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18 (1999) 5487-5496
29. Gardiol D., Zacchi A., Petrera F., Stanta G., and Banks L. Human discs large and scrib are localized at the same regions in colon mucosa and changes in their expression patterns are correlated with loss of tissue architecture during malignant progression. Int. J. Cancer 119 (2006) 1285-1290
30. Guy C.T., Webster M.A., Schaller M., Parsons T.J., Cardiff R.D., and Muller W.J. Expression of the neu proto-oncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89 (1992) 10578-10582
31. Humbert P., Russell S., and Richardson H. Dlg, Scribble and Lgl in cell polarity, cell proliferation and cancer. Bioessays 25 (2003) 542-553
32. Jager R., Herzer U., Schenkel J., and Weiher H. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Oncogene 15 (1997) 1787-1795
33. Jamerson M.H., Johnson M.D., Korsmeyer S.J., Furth P.A., and Dickson R.B. Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice. Br. J. Cancer 91 (2004) 1372-1379
34. Jerry D.J., Medina D., and Butel J.S. p53 mutations in COMMA-D cells. In Vitro Cell. Dev. Biol. Anim. 30A (1994) 87-89
35. Kennedy N.J., and Davis R.J. Role of JNK in tumor development. Cell Cycle 2 (2003) 199-201
36. Lane M.A., Romagnoli L., Cruise B., and Cohn G.M. Spontaneous conversion to estrogen receptor expression by the human breast epithelial cell line, MCF-10A. Oncol. Rep. 6 (1999) 507-511
37. Li Z., Calcar S.V., Qu C., Cavenee W.K., Zhang M.Q., and Ren B. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc. Natl. Acad. Sci. USA 100 (2003) 8164-8169
38. Liao D.J., and Dickson R.B. c-Myc in breast cancer. Endocr. Relat. Cancer 7 (2000) 143-164
39. Littlewood T.D., Hancock D.C., Danielian P.S., Parker M.G., and Evan G.I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23 (1995) 1686-1690
40. Lorenzo C., Mechler B.M., and Byant P.J. What is Drosophila telling us about cancer?. Cancer Metastasis Rev. 18 (1999) 295-311
41. Macara I.G. Parsing the polarity code. Nat. Rev. Mol. Cell Biol. 5 (2004) 220-231
42. Margolis B., and Borg J.P. Apicobasal polarity complexes. J. Cell Sci. 118 (2005) 5157-5159
43. Murtagh J., McArdle E., Gilligan E., Thornton L., Furlong F., and Martin F. Organization of mammary epithelial cells into 3D acinar structures requires glucocorticoid and JNK signaling. J. Cell Biol. 166 (2004) 133-143
44. Muthuswamy S.K., Li D., Lelievre S., Bissell M.J., and Brugge J.S. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat. Cell Biol. 3 (2001) 785-792
45. Nakagawa S., and Huibregtse J.M. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell. Biol. 20 (2000) 8244-8253
46. Nass S.J., and Dickson R.B. Defining a role for c-Myc in breast tumorigenesis. Breast Cancer Res. Treat. 44 (1997) 1-22
47. Navarro C., Nola S., Audebert S., Santoni M.J., Arsanto J.P., Ginestier C., Marchetto S., Jacquemier J., Isnardon D., Le Bivic A., et al. Junctional recruitment of mammalian Scribble relies on E-cadherin engagement. Oncogene 24 (2005) 4330-4339
48. Nelson W.J. Adaptation of core mechanisms to generate cell polarity. Nature 422 (2003) 766-774
49. Nilsson J.A., and Cleveland J.L. Myc pathways provoking cell suicide and cancer. Oncogene 22 (2003) 9007-9021
50. Osmani N., Vitale N., Borg J.P., and Etienne-Manneville S. Scrib controls Cdc42 localization and activity to promote cell polarization during astrocyte migration. Curr. Biol. 16 (2006) 2395-2405
51. Qin Y., Capaldo C., Gumbiner B.M., and Macara I.G. The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J. Cell Biol. 171 (2005) 1061-1071
52. Ramljak D., Coticchia C.M., Nishanian T.G., Saji M., Ringel M.D., Conzen S.D., and Dickson R.B. Epidermal growth factor inhibition of c-Myc-mediated apoptosis through Akt and Erk involves Bcl-xL upregulation in mammary epithelial cells. Exp. Cell Res. 287 (2003) 397-410
53. Reginato M.J., Mills K.R., Becker E.B., Lynch D.K., Bonni A., Muthuswamy S.K., and Brugge J.S. Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes. Mol. Cell. Biol. 25 (2005) 4591-4601
54. Reichmann E., Schwarz H., Deiner E.M., Leitner I., Eilers M., Berger J., Busslinger M., and Beug H. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 71 (1992) 1103-1116
55. Rodriguez-Boulan E., and Nelson W.J. Morphogenesis of the polarized epithelial cell phenotype. Science 245 (1989) 718-725
56. Sandgren E.P., Schroeder J.A., Qui T.H., Palmiter R.D., Brinster R.L., and Lee D.C. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res. 55 (1995) 3915-3927
57. Schoenenberger C.A., Andres A.C., Groner B., van der Valk M., LeMeur M., and Gerlinger P. Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription. EMBO J. 7 (1988) 169-175
58. Spandidos D.A., Pintzas A., Kakkanas A., Yiagnisis M., Mahera H., Patra E., and Agnantis N.J. Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue. Anticancer Res. 7 (1987) 1299-1304
59. Stewart T.A., Pattengale P.K., and Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38 (1984) 627-637
60. Stoll M., Corneliussen B., Costello C.M., Waetzig G.H., Mellgard B., Koch W.A., Rosenstiel P., Albrecht M., Croucher P.J., Seegert D., et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat. Genet. 36 (2004) 476-480
61. Tilli M.T., and Furth P.A. Conditional mouse models demonstrate oncogene-dependent differences in tumor maintenance and recurrence. Breast Cancer Res. 5 (2003) 202-205
62. Xiang B., and Muthuswamy S.K. Using three-dimensional acinar structures for molecular and cell biological assays. Methods Enzymol. 406 (2006) 692-701
63. Yu K., Ravera C.P., Chen Y.N., and McMahon G. Regulation of Myc-dependent apoptosis by p53, c-Jun N-terminal kinases/stress-activated protein kinases, and Mdm-2. Cell Growth Differ. 8 (1997) 731-742
64. Zarbalis K., May S.R., Shen Y., Ekker M., Rubenstein J.L.R., and Peterson A.S. A focused and efficient genetic screening strategy in the mouse: identification of mutations that disrupt cortical development. PLoS Biol. 2 (2004) E219
65. Zeitler J., Hsu C.P., Dionne H., and Bilder D. Domains controlling cell polarity and proliferation in the Drosophila tumor suppressor Scribble. J. Cell Biol. 167 (2004) 1137-1146